Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) has been offered in many institutions worldwide since the 1990s. Despite its …

Appendiceal mucinous neoplasms sometimes present with peritoneal dissemination, which
was previously a lethal condition with a median survival of about 3 years. Traditionally …

Background This randomized phase III study was to evaluate the efficacy and safety of
cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for …

Purpose The three principal studies dedicated to the natural history of peritoneal
carcinomatosis (PC) from colorectal cancer consistently showed median survival ranging …

Objective: To review the literature with regard to the incidence and prognostic significance of
peritoneal seeding during surgery for primary colorectal cancer (CRC), the incidence of …

Malignant ascites indicates the presence of malignant cells in the peritoneal cavity and is a
grave prognostic sign. While survival in this patient population is poor, averaging about 20 …

Introduction: In the past, peritoneal carcinomatosis, regardless of primary tumor type, has
always been a lethal condition. Recently, special treatments using cytoreductive surgery …

Peritoneal carcinomatosis is a common manifestation of digestive-tract cancer and has been
regarded a terminal disease with a short median survival. Over the past decade, a new …

The combination of complete cytoreductive surgery and perioperative intraperitoneal
chemotherapy provides the only chance for long-term survival for selected patients …

Background: Peritoneal carcinomatosis has been regarded as a lethal clinical entity.
Recently, aggressive treatments combining intraperitoneal chemohyperthermia (IPCH) with …